Friday 6 November 2026 Export BDX’s income statement to Excel — free account

Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Revenue: −10.5%
EPS: +48.5%
Free cash flow: −31.6%
Total debt: −23.8%

Quarter to September 2026, against a year earlier

212.21 1.34 −0.63%

Follow BDX

Alert me

Market cap: $58.2B
P/E: 51.1×
Fwd P/E: 39.2×
Dividend yield: 1.87%
F-score: 6/9
Altman Z: n/a
Beneish M: −2.76
Dividend safety: 51/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Becton, Dickinson and Company 8-K filed Jul 22, 2026

Period ended Jul 19, 2026 · Filed Jul 22, 2026 · accepted 6:58 AM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

Red flags

Officer departure Jul 22, 2026
Becton, Dickinson and Company reported the departure of an officer or director

8-K filed Jul 22, 2026 · The filing · sec.gov